Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

Laser Etching Effect on Application Mode of Universal Adhesive

25 de marzo de 2021 actualizado por: A Ruya Yazici, Hacettepe University

Clinical Evaluation of Cervical Composite Restorations Placed Using Universal Adhesive in Different Modes and Different Etching Methods

To evaluate the clinical performance of the restorations by applying the universal adhesive in different modes under the influence of different surface treatments, with Erbium Chromium:Yttrium-Scandium-Gallium-Garnet (Er,Cr:YSGG) laser and acid etching in non-carious cervical lesions.

Descripción general del estudio

Descripción detallada

Forty-one patients (at least five non-carious cervical lesions) have participated in this study. The non-carious cervical lesions in each patient were divided into five groups (total-etch mode with phosphoric acid, selective-etch mode with phosphoric acid, total-etch mode with laser, selective-etch mode with laser and self-etch mode) according to different modes and application methods of universal adhesive (Clearfil Universal Bond Quick, Kuraray). Lesions were restored with a resin composite, Clearfil Majesty ES-2 (Kuraray). All restorative procedures were performed by a single operator. Restorations were evaluated at one week (baseline), at 6-, 12-, 18- and 24-month according to modified USPHS criteria (retention, marginal discoloration, marginal adaptation, color match, postoperative sensitivity, and secondary caries) by two experienced and calibrated investigators.

Tipo de estudio

Intervencionista

Inscripción (Actual)

41

Fase

  • No aplica

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Ubicaciones de estudio

      • Ankara, Pavo, 06100
        • Hacettepe University Faculty of Dentistry

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

18 años a 75 años (Adulto, Adulto Mayor)

Acepta Voluntarios Saludables

Géneros elegibles para el estudio

Todos

Descripción

Inclusion Criteria:

  • Participants were 18 years of age or older,
  • no possible health problems (such as allergies) related to resin-based restorations,
  • good general health,
  • having at least five non-carious cervical lesions.
  • The depth of the lesions were at least 1 mm, without carious, not previously restored, having teeth with vital, enamel and dentin tissue.

Exclusion Criteria

  • Participant had fewer than 20 teeth,
  • having poor oral hygiene,
  • uncontrolled periodontal disease,
  • xerostomia,
  • pregnancy or breastfeeding possible health problems (such as allergy) related to resin-based restorations,
  • having bleaching treatment or orthodontic treatment.

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

  • Propósito principal: Tratamiento
  • Asignación: Aleatorizado
  • Modelo Intervencionista: Asignación paralela
  • Enmascaramiento: Ninguno (etiqueta abierta)

Armas e Intervenciones

Grupo de participantes/brazo
Intervención / Tratamiento
Otro: Group I
Total-etch mode with 35% phosphoric acid
35% phosphoric acid was applied to enamel and dentin for 10 s, washed and dried for 5 s. The universal adhesive, Clearfil Universal Bond Quick (CBQ) was applied to enamel and dentin surfaces with a single-use applicator, then gently air-dried for 5 s without waiting, and light-cured for 10 s.
Otro: Group II
Selective-etch mode with 35% phosphoric acid
35% phosphoric acid was used only on enamel for 10 s, then washed and dried for 5 seconds. Subsequently, the adhesive was applied in a similar manner to the TE-A group.
Otro: Group III
Total-etch mode with laser (Er,Cr:YSGG)
the enamel margin and dentin surfaces of lesions were irradiated with an Er,Cr:YSGG laser (2780 nm, Waterlase MD, BioLase Technology, Inc., San Clemente, CA). Then the adhesive was applied in a similar manner to the TE-A group.
Otro: Group IV
Selective-etch mode with laser (Er,Cr:YSGG)
The laser system was applied in the same way as described in the TE-L group only on enamel surface. Subsequently, the adhesive was applied in the same way as described in the TE-A group.
Otro: Group V
Self-etch mode
Universal adhesive system (CBQ) was applied to enamel and dentin surfaces without any previous etching. Then gently air-dried for 5 s without waiting, and light-cured for 10 s.

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Retention,
Periodo de tiempo: From baseline to 2 year the change of restorations was evaluated

The retention criterion determines how long a restorative material functions in the oral environment, it is the most important criterion that shows the success of the material.

Alpha: The restoration is present. Charlie: The restoration is absent.

From baseline to 2 year the change of restorations was evaluated
Marginal Discoloration
Periodo de tiempo: From baseline to 2 year the change of restorations was evaluated

The marginal discoloration that occur at the edge staining restoration boundaries are generally thought to be due to microleakage.

Alpha: No discoloration at margins. Bravo: Shallow discoloration, clinically acceptable. Charlie: Deep discoloration clinically unacceptable.

From baseline to 2 year the change of restorations was evaluated
Marginal Adaptation
Periodo de tiempo: From baseline to 2 year the change of restorations was evaluated

Marginal adaptation is achieved by fully ensuring the integrity of the tooth-restoration joint border.

Alpha: Restoration is closely adapted to the tooth. Bravo: Visible evidence of a crevice along the margin, dentin not exposed, clinically acceptable.

Charlie: Explorer penetrates into crevice, dentin is exposed; clinically unacceptable.

From baseline to 2 year the change of restorations was evaluated
Color match
Periodo de tiempo: From baseline to 2 year the change of restorations was evaluated

Color match is the evaluation of the restoration according to the darkening or lightening of the color, taking into account the tooth tissue surrounding restoration.

Alpha:Matches tooth. Bravo: Acceptable mismatch. Charlie:Unacceptable mismatch.

From baseline to 2 year the change of restorations was evaluated
Post-op Hypersensitivity
Periodo de tiempo: From baseline to 2 year the change of restorations was evaluated
Determination of sensitivity after restorations are placed. Alpha: Absent. Charlie: Present; clinically unacceptable.
From baseline to 2 year the change of restorations was evaluated
Secondary Caries
Periodo de tiempo: From baseline to 2 year the change of restorations was evaluated

Secondary caries is the progression of caries in the tooth tissue adjacent to the restorations. Caries formation means restoration failure.

Alpha: Absent. Charlie: Present; clinically unacceptable.

From baseline to 2 year the change of restorations was evaluated

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Patrocinador

Investigadores

  • Investigador principal: A. Ruya Yazici, Hacettepe University Faculty of Dentistry

Publicaciones y enlaces útiles

La persona responsable de ingresar información sobre el estudio proporciona voluntariamente estas publicaciones. Estos pueden ser sobre cualquier cosa relacionada con el estudio.

Enlaces Útiles

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio (Actual)

10 de julio de 2019

Finalización primaria (Actual)

10 de enero de 2021

Finalización del estudio (Anticipado)

25 de marzo de 2025

Fechas de registro del estudio

Enviado por primera vez

11 de marzo de 2021

Primero enviado que cumplió con los criterios de control de calidad

23 de marzo de 2021

Publicado por primera vez (Actual)

24 de marzo de 2021

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

26 de marzo de 2021

Última actualización enviada que cumplió con los criterios de control de calidad

25 de marzo de 2021

Última verificación

1 de marzo de 2021

Más información

Términos relacionados con este estudio

Otros números de identificación del estudio

  • KA180076

Información sobre medicamentos y dispositivos, documentos del estudio

Estudia un producto farmacéutico regulado por la FDA de EE. UU.

No

Estudia un producto de dispositivo regulado por la FDA de EE. UU.

No

producto fabricado y exportado desde los EE. UU.

No

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .

Suscribir